These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21233071)
1. Drug eruption and exacerbation of psoriasis related to bupropion. Gómez-Fernández C; Herranz Pinto P; Casado Verrier B; Sendagorta Cudós E; Beato-Merino MJ; Jiménez MC Eur J Dermatol; 2011; 21(1):120-1. PubMed ID: 21233071 [No Abstract] [Full Text] [Related]
2. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. Surovik J; Riddel C; Chon SY J Drugs Dermatol; 2010 Aug; 9(8):1010-2. PubMed ID: 20684153 [TBL] [Abstract][Full Text] [Related]
3. Pityriasis rosea-like drug eruption due to bupropion: a case report. Polat M; Uzun Ö; Örs I; Boran Ç Hum Exp Toxicol; 2014 Dec; 33(12):1294-6. PubMed ID: 24700110 [TBL] [Abstract][Full Text] [Related]
4. Bupropion and generalized acute urticaria: a further case. Loo WJ; Alexandroff A; Flanagan N Br J Dermatol; 2003 Sep; 149(3):660. PubMed ID: 14511012 [No Abstract] [Full Text] [Related]
5. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Cox NH; Gordon PM; Dodd H Br J Dermatol; 2002 Jun; 146(6):1061-3. PubMed ID: 12072078 [TBL] [Abstract][Full Text] [Related]
6. [Adverse effects of Zyban (bupropion) used in smoke cessation]. Jensen JB Ugeskr Laeger; 2001 Nov; 163(46):6455. PubMed ID: 11816933 [No Abstract] [Full Text] [Related]
7. [Convulsions in association with bupropion]. Solano Remírez M; Alvarez Frías MT; González Arencibia C; Gutiérrez Dubois J; Llorente Díaz B An Med Interna; 2005 Aug; 22(8):396-8. PubMed ID: 16358429 [No Abstract] [Full Text] [Related]
8. Acute psychosis after administration of bupropion hydrochloride (Zyban). Neumann M; Livak V; Paul HW; Laux G Pharmacopsychiatry; 2002 Nov; 35(6):247-8. PubMed ID: 12518275 [No Abstract] [Full Text] [Related]
9. [Uneasiness about the safety of bupropion as an aid to smoking cessation unjustified]. Offerhaus L Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2054. PubMed ID: 11695106 [No Abstract] [Full Text] [Related]
13. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Joseph AM; Fu SS Prog Cardiovasc Dis; 2003; 45(6):429-41. PubMed ID: 12800126 [TBL] [Abstract][Full Text] [Related]
14. [Zyban in smoking cessation--where is physician's ethic?]. Jacobsen CD Tidsskr Nor Laegeforen; 2001 Jan; 121(1):107-8. PubMed ID: 12013602 [No Abstract] [Full Text] [Related]
15. [Zyban in smoking cessation]. Flaten O Tidsskr Nor Laegeforen; 2001 Feb; 121(4):507-8. PubMed ID: 11255877 [No Abstract] [Full Text] [Related]
16. Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Bagshaw SM; Cload B; Gilmour J; Leung ST; Bowen TJ Ann Allergy Asthma Immunol; 2003 May; 90(5):572-5. PubMed ID: 12775141 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of nicotine addiction. Drug therapy for smoking cessation]. Pedersen ST; Christensen HR; Døssing M Ugeskr Laeger; 2002 Mar; 164(11):1480-4. PubMed ID: 11924470 [TBL] [Abstract][Full Text] [Related]
18. A comparison of sustained-release bupropion and placebo for smoking cessation. Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378 [TBL] [Abstract][Full Text] [Related]
20. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology. Yamamoto M; Ikeda M; Kodama H; Sano S J Dermatol; 2008 Nov; 35(11):732-6. PubMed ID: 19120769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]